These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 34845)

  • 41. Pisa syndrome after discontinuation of clotiapine in a patient with intractable insomnia.
    Wang EH; Yang AC
    J Clin Psychopharmacol; 2014 Apr; 34(2):276-7. PubMed ID: 24525650
    [No Abstract]   [Full Text] [Related]  

  • 42. Parkinsonism and dyskinesias during ethanol withdrawal.
    Neiman J; Borg S; Wahlund LO
    Br J Addict; 1988 Apr; 83(4):437-9. PubMed ID: 3395725
    [No Abstract]   [Full Text] [Related]  

  • 43. Pentazocine abuse and problems of withdrawal.
    Maxmen JS; Silberfarb PM; Plakun E
    Br J Psychiatry; 1975 Apr; 126():370-1. PubMed ID: 238710
    [No Abstract]   [Full Text] [Related]  

  • 44. The mechanism of neuroleptic withdrawal.
    Eppel AB; Mishra R
    Can J Psychiatry; 1984 Oct; 29(6):508-9. PubMed ID: 6149010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Off-label antipsychotic use and tardive dyskinesia in at-risk populations: new drugs with old side effects.
    Remington G; Hahn M
    J Psychiatry Neurosci; 2014 Jan; 39(1):E1-2. PubMed ID: 24359929
    [No Abstract]   [Full Text] [Related]  

  • 46. Neuroleptics in the elderly: guidelines for monitoring.
    Sweet RA; Pollock BG
    Harv Rev Psychiatry; 1995; 2(6):327-35. PubMed ID: 9384918
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Persistent dystonia following opioid withdrawal.
    Aggarwal A; Kumar R; Sharma RC; Sharma DD
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):640. PubMed ID: 20685372
    [No Abstract]   [Full Text] [Related]  

  • 48. Monitoring for drug-induced movement disorders.
    Johnson BG
    Nursing; 2017 May; 47(5):56-60. PubMed ID: 28445339
    [No Abstract]   [Full Text] [Related]  

  • 49. [Systematic neuroleptic therapy with the appearance of parkinsonian states].
    FLUGEL F
    Encephale; 1956; 45(4):1090-2. PubMed ID: 13384343
    [No Abstract]   [Full Text] [Related]  

  • 50. Neuroleptics and abnormal movements.
    Lader MH
    Br Med J (Clin Res Ed); 1982 Aug; 285(6340):463-4. PubMed ID: 6125232
    [No Abstract]   [Full Text] [Related]  

  • 51. Dyskinesia, antipsychotic-drug exposure and risk factors in a developmentally-disabled population.
    Stone RK; Alvarez WF; May JE
    Pharmacol Biochem Behav; 1988 Jan; 29(1):45-51. PubMed ID: 2451256
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dystonia as a presenting feature of alcohol withdrawal.
    Bijjal S; Subodh BN; Narayanaswamy JC; Chand P; Benegal V; Murthy P
    J Neuropsychiatry Clin Neurosci; 2012; 24(1):E15-6. PubMed ID: 22450628
    [No Abstract]   [Full Text] [Related]  

  • 53. Maintenance antipsychotic trials and the effect of withdrawal.
    Munkholm K; Horowitz MA; Moncrieff J
    Lancet; 2022 Sep; 400(10357):995. PubMed ID: 36154688
    [No Abstract]   [Full Text] [Related]  

  • 54. Case study: neuroleptic withdrawal dyskinesia exacerbated by ongoing stimulant treatment.
    Connor DF; Benjamin S; Ozbayrak KR
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1490-4. PubMed ID: 8543517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Life-threatening neuroleptic withdrawal emergent syndrome resembling status dystonicus.
    Pugin D; Bally J; Horvath J; Pollak P; Gasche Y; Burkhard PR
    Parkinsonism Relat Disord; 2017 Feb; 35():96-97. PubMed ID: 27914829
    [No Abstract]   [Full Text] [Related]  

  • 56. Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE
    Psychiatr Clin North Am; 1993 Sep; 16(3):589-610. PubMed ID: 8105453
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroleptic withdrawal dyskinesia [proceedings].
    Escobar JI; Tuason VB
    Psychopharmacol Bull; 1979 Apr; 15(2):71-4. PubMed ID: 34845
    [No Abstract]   [Full Text] [Related]  

  • 58. Akinetic crisis, acute akinesia, neuroleptic malignant-like syndrome, Parkinsonism-hyperpyrexia syndrome, and malignant syndrome are the same entity and are often independent of treatment withdrawal.
    Thomas A; Onofrj M
    Mov Disord; 2005 Dec; 20(12):1671; author reply 1671-2. PubMed ID: 16149099
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.